CRISPR and Genome Editing Technologies
CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) and genome editing technologies have revolutionized the field of molecular biology by providing precise tools for modifying genetic material. Originally discovered as part of the bacterial immune system, CRISPR has been adapted into a powerful tool for editing genomes in various organisms, including humans. This technology has numerous applications in basic research, biotechnology, and medicine. Consists of CRISPR arrays and Cas proteins (e.g., Cas9, Cas12a). Allows for targeted editing of specific DNA sequences. The process of making precise changes to the DNA of a cell or organism. Besides CRISPR-Cas, other genome editing tools include TALENs (Transcription Activator-Like Effector Nucleases) and ZFNs (Zinc Finger Nucleases). Directs the Cas9 enzyme to the target DNA sequence. Cas9 creates a double-strand break (DSB) at the target site. Corrects mutations responsible for genetic diseases. Disrupts oncogenes or enhances tumor suppressor genes. Modifies stem cells for transplantation and tissue regeneration.Generates animal organs with human-compatible tissues. Developing more precise genome editing tools to minimize off-target effects. Advancing CRISPR-based therapies for a wide range of genetic disorders.
Related Conference of CRISPR and Genome Editing Technologies
20th World Congress on Tissue Engineering Regenerative Medicine and Stem Cell Research
18th International Conference on Human Genomics and Genomic Medicine
16th International Conference on Human Genetics and Genetic Diseases
19th International Conference on Genomics & Pharmacogenomics
CRISPR and Genome Editing Technologies Conference Speakers
Recommended Sessions
- Stem Cell Research and Therapy
- Cell and Tissue Engineering
- Bioinformatics and Systems Biology
- Cancer Biology and Cell Signaling
- Cell Cycle and Cell Division
- Cell Migration and Invasion
- Cellular Mechanotransduction
- Cellular Metabolism and Metabolic Disorders
- CRISPR and Genome Editing Technologies
- Developmental Biology and Regenerative Medicine
- Epigenetics and Epigenomics
- Microbiome and Host Interactions
- Molecular and Cellular Immunology
- Molecular Genetics and Gene Therapy
- Molecular Pathology and Diagnostics
- Nanotechnology in Cell Biology
- Neurobiology and Neurodegenerative Diseases
- Proteomics and Protein Engineering
- Signal Transduction and Cell
- Single-Cell Analysis and Applications
- Structural Biology and Molecular Dynamics
- Synthetic Biology and Bioengineering
Related Journals
Are you interested in
- Achieving efficient delivery and editing - CRISPR 2025 (Italy)
- Bioinformatics - HUMAN GENOME 2025 (France)
- Cancer and stem cells - CRISPR 2025 (Italy)
- Cancer Genomics - HUMAN GENOME 2025 (France)
- Cognitive Computing - HUMAN GENOME 2025 (France)
- Computational Biology - HUMAN GENOME 2025 (France)
- CRISPR technologies and society - CRISPR 2025 (Italy)
- CRISPR technologies beyond genome editing and gene regulation - CRISPR 2025 (Italy)
- Drug Detection & Development in Bioinformatics - HUMAN GENOME 2025 (France)
- Emergency Medicine - HUMAN GENOME 2025 (France)
- Epigenetics Biomarkers - HUMAN GENOME 2025 (France)
- Genetically Modified Organisms - HUMAN GENOME 2025 (France)
- Genome editing and gene regulation in human health - CRISPR 2025 (Italy)
- Genome editing and gene regulation in industrial bacterial biotechnology - CRISPR 2025 (Italy)
- Genome editing and gene regulation in industrial eukaryotic biotechnology - CRISPR 2025 (Italy)
- Genome Editing Methods and Novel Tools - CRISPR 2025 (Italy)
- Genome Mapping - HUMAN GENOME 2025 (France)
- Genomic Approach to Drug Discovery - HUMAN GENOME 2025 (France)
- Genomic Information in Medicine - HUMAN GENOME 2025 (France)
- Genomic Vaccination - HUMAN GENOME 2025 (France)
- Genomics - HUMAN GENOME 2025 (France)
- Horizons of CRISPR biology - CRISPR 2025 (Italy)
- Human Gene Therapy - HUMAN GENOME 2025 (France)
- Human Genetics - HUMAN GENOME 2025 (France)
- Infectious Diseases - HUMAN GENOME 2025 (France)
- Medicine Genomics - HUMAN GENOME 2025 (France)
- Personalized Medicine - HUMAN GENOME 2025 (France)
- Pharma Genomics & Pharma Informatics - HUMAN GENOME 2025 (France)
- Plant and Animal Biotechnology - CRISPR 2025 (Italy)
- Preimplantation Genetic Diagnosis - HUMAN GENOME 2025 (France)
- Structural Biology and Bioinformatics - CRISPR 2025 (Italy)
- Therapeutic Genome Editing - CRISPR 2025 (Italy)